Sahm Adrangi, the 21st Century Investment Banker

Sahm Adrangi, the 21st Century Investment Banker
Sahm Adrangi first shot into the limelight in 2010 when he exposed dishonest Chinese companies and benefited by selling their stocks short. Some of the companies include China Marine Food Group, Lihua International, and China-Biotics. Other companies that were on Sahm’s target list including China Education Alliance and ChinaCast Corporation suffered significant scrutiny by the Securities and Exchange Commission (SEC).
Besides his 2010 actions, Sahm Adrangi is also famous for sharing his company’s trading tips particularly on shorting stocks. He regularly publishes market research on the Kerrisdale’s website, Twitter, and other investor-related platforms. Some of his published content includes reports on overvalued stocks, fundamental and technical analysis of specific equities, misunderstood market information, and stock value predictions.
Recently, Sahm Adrangi is aggressively diverting investor funds to the biotechnology, and mining industries. According to him, company stocks in this sector are under-valued, and investors are soon going to see an upward trend in equity prices. Sahm has published many articles on biotechnology companies such as Bavarian Nordic, Zafgen, and Pulse Biosciences. In the mining sector, he is quite optimistic about the performance of First Majestic Silver and Northern Dynasty Minerals.
About Sahm Adrangi
Sahm Adrangi graduated from Yale University with a Bachelor of Arts degree in Economics. He began his career in finance as a credit officer as well as a bankruptcy and restructuring advisor at Deutsche Bank. He would later move to Chanin Capital partners to try his luck in investment banking.
Sahm’s experience as an investment banker landed him a job at Longacre Management, a multi-billion hedge fund specializing in distressed debt. In 2009, he established Kerrisdale Capital Management with just under $1 million in assets. As at July 2017, the company had a total of $150 million assets under management (AUMs). Adrangi also doubles up us the company’s Chief investment officer.
Apart from investment banking, Sahm is an investor activist. For instance, he led a contest to lobby proxies to elect directors from his slate at Morgan’s Hotel Group. Sahm is also a speaker having featured in numerous investor platforms including the Value Investing Conference and the Activist Investor Conference.

Jordan Lindsey: Profiting from Patterns

Anyone can become a forex millionaire. That is if they can yield a consistent 7 percent return monthly, and compound the interest for ten years. Such a stellar result would equate to a 100 percent annualized return based on the math. In an age when a one year CD does not typically yield a 1 percent return, such a claim may seem far-fetched. Anyone who is familiar with the types of results which are possible trading forex can attest that such astronomical returns are indeed achievable.

Mr. Jordan Lindsey has been encouraging forex traders for years. He is well familiar with the possibilities of the forex market to change a person’s life once he or she learns the correct methodology. Trading is not gambling there is a science and an art to it. It is inadvisable that anyone dabbles in the forex market without first equipping themselves with the necessary knowledge.

Key to this knowledge base is the field of technical analysis. Technical analysis is the field which most traders depend on to predict future prices. Thus making it possible to execute informed trading decisions. Price charts and the patterns they present are the fundamental tools of this discipline. Chart patterns are dependable, which is what makes technical analysis worthwhile. Some examples of the statistical performance of these charts are as follows:

Ascending Triangle 73% reliable

Channel Up 72% reliable

Channel Down 74% reliable

Descending Triangle 71% reliable

Double Bottom 80% reliable

These are, but a few of the chart patterns commonly exploited in forex trading. None are 100 percent accurate. However, each pattern represents a situation where traders have an edge in predicting the future moves in the market. To achieve Jordan Lindsey’s 7 percent monthly return, traders must exploit reliable chart patterns which give them an edge.

A plan with positive expectancy is what you need to become a professional forex trader. Knowing chart patterns and their probabilities will give you the confidence to execute your trade plan and adhere to it. As Jordan Lindsey has said, ideas are not what makes people wealthy. It is execution and persistence. Profitable traders are traders who manage to adhere to their plans while keeping their dream alive.

Elysium—a New Health Company

Elysium Health was founded in 2014 by Dr. Leonard Guarente, the director of the Glenn Center for Biology of Aging Research at MIT. During his career, Dr. Guarente has conducted significant research on molecular and genetic causes of aging.

Basis is a daily supplement created by Elysium Health. The supplement works to increase the levels of the coenzyme NAD+ in our cells. NAD+ is essential in many cellular processes like DNA protection and energy creation. As we age, our levels of NAD+ decline and those functions break down. So, by increasing NAD+ levels, Basis supports those cellular functions and our cellular health as a result.

A clinical trial was conducted in 2016 to prove the efficacy of Basis. 120 people were divided into three equal groups, with one taking the recommended dose, another taking double the recommended dose, and the third group taking a placebo. The group which took the recommended dose of Basis saw their NAD+ levels increase by an average of 40 percent over the course of several weeks. The results of the study were published in the online scientific journal npj: Aging and Mechanisms of Disease.

Basis is available for purchase through the Elysium Health’s website. The supplement comes in jars, with each jar containing 60 capsules of Basis. The daily recommended dose of Basis is two capsules, so each jar has a 30-day supply of the supplement. A single jar costs $60. A monthly subscription to Basis costs $50 per month and a prepaid six-month subscription brings to cost to an even lower $45 per jar.

More information on Elysium Health, the company’s team, and the science behind Basis can be found on Elysium’s website.

The Rebirth of UTC Under Louis Chenevert

He holds a Bachelor’s degree in the field of production management. This, he acquired from HEC Montreal, an associate of the University of Montreal. He first started working with the General Motors for 14 years. In addition to his already glamorous portfolio, the man also has a doctorate from HEC Montreal which he received in 2011, and the title 2011’s person of the year by Aviation Week and Space Technology, a United States aviation trade magazine. He is the former CEO and chairman of United Technologies cooperation (UTC), ex-president of Pratt and Whitney Canada. He is the up-and-coming Canadian businessman, Louis Chenevert.

Louis Chenevert was elected chairman and CEO of United Technologies Cooperation (UTC) in 2006. UTC is an offshore cooperation that works with both noncombatant and military economies in manufacturing a wide range of products. These products include security systems, elevators, HVASs and aircraft engines.

During his time as CEO and chairman at UTC, Chenevert made a chain of enhancements in the organization with the intention of segregating the company from the profit losses that most businesses sustained at the time. Most companies at this time were resorting to outsourcing strategy to face the financial crisis. Well, Chenevert was wiser; he instead decided to move all of UTC’s engineers and workers into the United States. His objective was at bringing all of the best thinkers and workers in one area where they would focus on solving problems together and producing quality products that would bring in more income as compared to the cheap products that result from cheap labor. This move went on to help the company keep itself afloat during the hard period of the Great Recession. The company incredibly increased their stock value under the leadership of Louis Chenevert.

Louis Chenevert stepped down from his position as CEO and chairman of UTC in December 2014 after a successful run. His greatest achievement in UTC is that he led the corporation to achieve a balance in its portfolio of various businesses that cater to diverse users in different markets.

Volcanic Filtered and Eco-Friendly Waiakea Water

A few decades ago people really didn’t even consider purchasing bottles water. Why buy something in a bottle that you could just get from your sink? It didn’t make much sense. Unless you lived in an area where your faucet water wasn’t safe to consume this just wasn’t a common purchase to make. Over the past two decades an increase in the popularity of bottled water has surged. People purchase bottled water for all types of reasons. Standing in front of a water cooler at a convenience store will boast dozens of options.

What makes one brand of water better than another? Is it the awesome packaging? Is it the price? Is it because it is from a region that just seems like a desirable place to bottle water? Each brand of bottled water needs to come up with a distinguishing factor to make it stand out above the competition.

Waiakea Water is a rather new to the market brand of bottled water. Waiakea Water was established in 2012 and has been making waves in the water industry scene since its launch. One amazing fact about Waiakea Water is that it is commonly dubbed as Hawaii volcanic water. What exactly makes it volcanic water? Waiakea Water is filtered through a process in which it runs 14,000 feet down the Mauna Loa volcano through porous volcanic rock. This process actually creates a pH level anywhere from 7.6 to 8.2. This makes Waiakea Water one of the most natural alkaline waters available for purchase. There are many health benefits to drinking alkaline water. This form of filtration infuses the water with many minerals including magnesium and calcium.

The Waiakea Water bottle is also a rather notable water bottle. The bottle that they have created is the world’s first fully degradable water bottle which makes it completely eco-friendly. In addition to this biodegradable bottle Waiakea Water also is certified Carbon Neutral. They use only low emission vehicles when delivering their product. Waiakea Water also donates three percent of their sales to local community programs and they donate one liter of drinking water to Malawi for every liter of water that a consumer purchases. Waiakea Water is a company that wants to make a positive impact on the World by giving back, creating a low carbon foot print and providing a quality and unique product.

Jeunesse Global Creates Highly Touted Y.E.S. System

Jeunesse Global, one of the fastest-growing companies in the global health and beauty sector, has recently unveiled its total beauty system, which consists of more than a dozen of the company’s most popular products. Known as the YES System, this comprehensive health and beauty regime allows people to feel better, get a better night’s sleep and look their best.

The YES System is the culmination of years of product development. Jeunesse has always focused on creating products that meet the specific health and beauty needs of niche markets. Now, it is offering a far more comprehensive health and beauty system, which is designed to meet the needs of busy professionals and others who lead an active lifestyle.

The YES System also enables buyers to avoid having to go to multiple different sources to get their products. This eliminates considerable hassle in finding all of the essential health and beauty tools that one needs to stay at the top of their game. In this sense, the YES System is a sort of one-stop shopping experience, but those who purchase it never even need to leave their homes!

Among the products contained within this revolutionary new system are the company’s wildly popular skincare crème. Known as Luminesce, the product was developed for use by people all over the globe. It comes in nine different skin shade colors, allowing users to match their own skin color. For markets in East Asia and elsewhere, Luminesce can also act as a powerful skin whitening crème, making it able to accomplish multiple beauty tasks in one product.

The secret behind Luminesce is its use of a proprietary molecule synthesized especially for use in the company‘s products. Known as APT-200, the molecule has been scientifically proven to restore skin elasticity, conceal wrinkles and give a youthful, vibrant glow to users’ skin. The crème only requires one application per day, allowing the user to engage in a stressful and highly active lifestyle without worrying about having to constantly reapply their skincare products.

These are just a few of the exciting innovations coming out of the Jeunesse research and development labs.

Scott Rocklage Continues to Expand Reserach for DM1 Disorders

Recently Expansion Therapeutics raised over $55.3 million for research for the development of drugs that target genetic diseases that cause adult muscular dystrophy. The financing was lead by several companies including 5AM Ventures.

DM1 a substance that causes these genetic repeat disorders is caused by production of toxic molecules that turn into proteins inside the cells. This leads to problems with the heart, nervous system, respiratory system, muscles, stomach, and hormones. This can affect entire families and to date there is no known treatment for the disease. Read more: Scott Rocklage | Ideamesch and Scott Rocklage | Angel

Expansion Therapeutics specializes in developing drugs that target diseases caused by RNA. It focuses on disease that have no treatment or cure. Scott M. Rocklage managing partner of 5M Ventures and chairman of the board of directors of Expansion Therapeutics says the drugs they develop are based on research performed by Matthew D. Disney Ph.D of Scripps Research Institute.

Rocklage said that Disney was the key scientific founder of the team The company has put together a research team and a plan to advance the field of RNA medicine. They want to develop new medicines for patients that have few treatment options available.

Scott Rocklage went to the University of California Berkley. He received a B.A. in Chemistry. Later he went on to receive a Ph.D in Chemistry from the Massachusetts Institute of Technology. While at MIT he conducted research and worked in the lab.

In 2005, he received the Nobel Peace Prize in Chemistry. He joined 5AM Ventures in 2003 as a venture partner and later became a managing partner. Dr. Rocklage was responsible for FDA approval of three drugs. He has submitted numerous drugs for clinical trail studies.

Scott Rocklage owns over 30 US patents and many of his articles published have been peer reviewed. At one time he was chairman and CEO of Cubist Pharmaceuticals and held many R & D positions at different companies.

Ted Bauman Helps Clients Realize Investing Potential

In his position as an investment advisor, Ted Bauman has tried to always give people the chances they need for investment. In fact, he has always wanted to make sure he can give back to the clients he works with. If he can give them positive investment advice, he knows it will give him the chances he needs to continue being successful at both Banyan Hill Publishing and the Bauman Letter. Ted Bauman likes to show his customers they can try different things and they can do more with the industry standards he has put into place.

In addition, Ted Bauman has always wanted to let his customers know there will be a positive part that comes from the industry. He has shown them the right way to help themselves and the right investments they need, now he hopes they will be able to use the strategies on their own. Instead of just taking the money from them and investing it at will, Ted Bauman shows them how they can use their own money and invest it by themselves. As an advisor, he wants to teach people what they can do to make money instead of what they will need to do to try to work with him only. Read more about Ted Bauman at Ezine Articles

One thing Ted Bauman has vehemently insisted on is that Bitcoin is a poor investment choice. Not only is it hard to invest in something that doesn’t exist in real life, but it makes things worse for people who want to actually make money. They will not be able to use the cryptocurrency in the same way they would use other types of money. In fact, it would just not even be as fast as a credit card transaction if they wanted to be able to make a difference in the money they were using.

Cryptocurrency has no future as a currency. People who are trying to invest their money will soon realize the currency portion won’t work. It is hard for others to grasp because they know they can use it online, but it takes much longer to use it in a brick and mortar setting. It can take almost an hour to complete a transaction. In the busy world that is all around people, it would not make sense to have to wait an hour to get the currency they need or to pay for the things they can use.

Check this link:http://www.talkmarkets.com/contributor/Ted-Bauman

 

Can the Fear-mongering Commodity Uranium Make a Price Comeback in 2018?

Is the fearsome and a potentially high damage causing commodity uranium about to see better times ahead after peaking at its lowest in October 2016? Quite possibly yes, as per Matt Badiali’s analysis for uranium in 2018.

The downfall of uranium began in 2011 after the frightening occurrence of the Fukushima disaster in Japan. It alerted everyone to its high potential of causing energy disasters in the aftermath of unpreventable failures such as earthquakes and tsunamis.

The uranium price, before its downtrend, was sold for $72.50 per pound in January 2011. It fell to a shocking low price of $18.75 per pound in 2016. The steady decline of uranium came as a shocking reality, considering the “green” status attributed to it. Even the belief (as held by many) that uranium reduces greenhouse emission, compared to its counterpart hydrocarbon, couldn’t aid its fall.

Apparently, the Fukushima natural disaster enabled many to realize the storage problems of uranium and it seems they plan to cling to this perception for now. But what exactly was so impactful in retaining this concern?

When the earthquake and tsunami struck the region of Fukushima Daiichi nuclear power plant in March 2011, the earth disaster damaged a reactor. This was followed by the tsunami that inundated the area, destroying the backup generators that were supposed to maintain the temperature in the absence of the main power source. Without any functioning power, the cooling water couldn’t reach the plant to prevent radiation meltdown. This paved way for the greatest nightmare of any nuclear power plant operator to come true.

A lack of foresight into possible mishaps contributed to this error largely. The Tokyo Electric Power Company that operated the nuclear plant was unprepared for this situation. The result created a rippling effect. Many countries became wary of nuclear power reactors, with Germany going so far as to shut down all its nuclear reactors. As a result, demand for uranium fell and so did its price.

In November 2017, the uranium production mine, Cameco Corp, cut production after continuing to witness the fall of uranium prices. The struggle to maintain profitability, led to the decision to suspend operations for ten months at its flagship McArthur River mine. Kazatomprom, Kazakhstan’s state-sponsored uranium miner, followed suit and cut down on uranium production by 20%.

Matt Badiali’s chart demonstrated that shares of Uranium Participation Corp. dropped in response to this development. Shares of other uranium companies plunged as well.

Analysts believe the price of uranium can gain $30 per pound from these cuts in the coming year. This possibility will be a windfall for uranium producers. Companies like Cameco will experience revenue and earnings spike up. This trend will be closely observed into 2018.

Energy expert Matt Badiali, has an in depth knowledge in mining, agricultural and fossil industries. He’s analyzed many CEO schemes and observed trends in the stock market. His foresight is based off his experience and knowledge regarding many different fields in which he has closely interacted with professionals and experts. He continues to enlighten us with his perceptible predictions regarding good and useful investments.

Follow:https://twitter.com/Matt_B_Guru

Legacy Building

Compensating employees with stocks is not always the best way to go, especially with so much regulator scrutiny placed on most all transactions of an appreciable size. Jeremy Goldstein, an attorney with his own firm who advises on all kinds of employee compensation packages, has an alternative to stock options for senior level executives. The solution he has is called a “knockout option.” There are a number of reasons why stock options are not good, including stock value drops, which serve to negate the selling option often times, and for employers, they represent an accounting challenge. The costs of managing these options are greater than the benefits of the programs at times.

 

Knockout options have most of the same features as stock options, including time limits and tenure-of-service clauses, but they differ in what happens if the stock value falls under a certain amount. Employees will lose knockout options if a preset value is breached. These types of options give employees the right to purchase stock at a particular price, and invariably a 50% drop from the knockout option price will mark the expiration value. This is not automatic, however, and most of the time these deals are structured so that the price has to remain below the expiration value for a period of time, perhaps a week.

 

Prior to starting his own firm specializing in helping companies manage employee compensation packages, Jeremy Goldstein worked on a number of large-scale acquisitions as a partner at a large New York law firm. During that time he worked on several M&A deals, including Goldman Sachs and Kinder Morgan, and the Verizon Wireless/Alltell deal. He also served on the American Bar Association’s Executive Compensation Committee.

 

A stalwart in his field, Mr. Goldstein was nominated top legal talent in executive compensation by the publication “Legal 500.” Having graduated from the University of Chicago, with honors, and going on to New York University School of Law, where he received his J.D., Jeffrey Goldstein is creating a legacy of great work in employee compensation plans that work for employees and employers alike. Learn more: https://profiles.superlawyers.com/new-york-metro/new-york/lawfirm/jeremy-l-goldstein-and-associates-llc/a958e5a0-ace7-44fa-8f53-da9d83c3b29b.html